Two gene therapy approvals headline CBER’s FY 2018 report
The FDA Center for Biologics Evaluation and Research (CBER) on Wednesday published its fiscal year 2018 report, highlighting two gene therapy approvals, as well as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.